Population Pharmacokinetic and Exposure–Response Analyses for Efficacy and Safety of Risankizumab in Patients With Active Crohn's Disease
Suleiman, Ahmed Abbas, Goebel, Aline, Bhatnagar, Sumit, D'Cunha, Ronilda, Liu, Wei, Pang, Yinuo
Published in Clinical pharmacology and therapeutics (01.04.2023)
Published in Clinical pharmacology and therapeutics (01.04.2023)
Get full text
Journal Article
Population Pharmacokinetic and Exposure–Response Modeling to Inform Risankizumab Dose Selection in Patients With Ulcerative Colitis
Thakre, Neha, Goebel, Aline, Winzenborg, Insa, Suleiman, Ahmed A., D'Cunha, Ronilda, Mensing, Sven, Liu, Wei, Pang, Yinuo
Published in Clinical pharmacology and therapeutics (01.09.2024)
Published in Clinical pharmacology and therapeutics (01.09.2024)
Get full text
Journal Article